Journal:JBSD:30
From Proteopedia
(Difference between revisions)

Line 1: | Line 1: | ||
- | <StructureSection load='' size='450' side='right' scene='' caption=''> | + | <StructureSection load='' size='450' side='right' scene='Journal:JBSD:30/Cv/2' caption=''> |
=== Conformational dynamics of full-length inducible human Hsp70 derived from microsecond molecular dynamics simulations in explicit solvent === | === Conformational dynamics of full-length inducible human Hsp70 derived from microsecond molecular dynamics simulations in explicit solvent === | ||
<big>Adrien Nicolaï, Patrice Delarue and Patrick Senet</big> <ref>REF</ref> | <big>Adrien Nicolaï, Patrice Delarue and Patrick Senet</big> <ref>REF</ref> | ||
<hr/> | <hr/> | ||
<b>Molecular Tour</b><br> | <b>Molecular Tour</b><br> | ||
+ | |||
1. Hsp70, molecular chaperone | 1. Hsp70, molecular chaperone | ||
The 70 kDa heat shock proteins (Hsp70s) are major ATP-dependent molecular chaperones involved in the general folding assisted pathways and are present in all eukaryotic and prokaryotic cells. Hsp70s assist a wide range of folding processes; including the folding of newly synthesized proteins and the refolding of misfolded and aggregated proteins. Other functions of Hsp70s include protein degradation, translocation of peptides across the cell membrane, formation of protein complexes, and inhibition of the programmed cell death. Consistent with the fact that Hsp70s interact with hundreds of client proteins of the intracellular environment and with its key role in the “conformational homeostasis” of cellular proteins, human Hsp70 (hHsp70) are involved in numerous diseases, such as neurodegenerative diseases and cancer. The diversity of hHsp70 implications in these diseases explains that they become recently an important target for the development of new therapeutic strategies. | The 70 kDa heat shock proteins (Hsp70s) are major ATP-dependent molecular chaperones involved in the general folding assisted pathways and are present in all eukaryotic and prokaryotic cells. Hsp70s assist a wide range of folding processes; including the folding of newly synthesized proteins and the refolding of misfolded and aggregated proteins. Other functions of Hsp70s include protein degradation, translocation of peptides across the cell membrane, formation of protein complexes, and inhibition of the programmed cell death. Consistent with the fact that Hsp70s interact with hundreds of client proteins of the intracellular environment and with its key role in the “conformational homeostasis” of cellular proteins, human Hsp70 (hHsp70) are involved in numerous diseases, such as neurodegenerative diseases and cancer. The diversity of hHsp70 implications in these diseases explains that they become recently an important target for the development of new therapeutic strategies. | ||
+ | |||
2. Structure of Hsp70 | 2. Structure of Hsp70 | ||
All Hsp70s are comprised of two main domains, a N-terminal Nucleotide Binding Domain (NBD) of 45 kDa and a C-terminal substrate binding domain (SBD) of 25 kDa. The NBD is divided into two rather symmetrical lobes, I and II, each divided into two subdomains A and B. The two lobes form the two arms of a V-shaped structure in which the nucleotide (ADP or ATP) is bound at the center. The SBD is further divided into a β sandwich subdomain (SBD-β) which has a hydrophobic peptide binding pocket, and a α-helical “lid” subdomain (SBD-α) which regulates the access of the substrate to the SBD-β. The NBD and the SBD are connected by a conserved hydrophobic linker. | All Hsp70s are comprised of two main domains, a N-terminal Nucleotide Binding Domain (NBD) of 45 kDa and a C-terminal substrate binding domain (SBD) of 25 kDa. The NBD is divided into two rather symmetrical lobes, I and II, each divided into two subdomains A and B. The two lobes form the two arms of a V-shaped structure in which the nucleotide (ADP or ATP) is bound at the center. The SBD is further divided into a β sandwich subdomain (SBD-β) which has a hydrophobic peptide binding pocket, and a α-helical “lid” subdomain (SBD-α) which regulates the access of the substrate to the SBD-β. The NBD and the SBD are connected by a conserved hydrophobic linker. | ||
+ | |||
3. The Hsp70 functional cycle | 3. The Hsp70 functional cycle | ||
- | The Hsp70s assists in the folding of other proteins through cycles of binding and release of unfolded polypeptide chains in the SBD (Figure 1). The cycle is governed by the nucleotide-binding status of the NBD: in the ATP-bound Hsp70, the SBD is opened with fast binding and release of the protein substrate and the SBD and the NBD are docked (Figure 1), whereas in the ADP-bound and nucleotide-free states (APO), the SBD is assumed to be closed with low binding and release rate of the protein substrate, with the SBD and the NBD undocked (Figure 1). The transition between the ATP (open conformation) and the ADP states of Hsp70 (closed conformation) is triggered by the ATP binding to the NBD, which induces a conformational change of the interdomain linker, and the opening of the SBD through an allosteric mechanism which is not fully elucidated. The ATP hydrolysis restores the closed conformation of the SBD. Rebinding of ATP to the nucleotide-free Hsp70 restarts the cycle of the chaperone. In vivo, the ATP hydrolysis and nucleotide exchange rates are increased by co-chaperones. Because of their critical roles in many cellular processes and based on evidence that their mechanisms involve cycles of conformational changes, there has been a strong interest in elucidating the structures of human Hsp70 in its two main conformations, i.e. ATP and ADP-bound. Structures of human Hsp70 are of first interest for the design of drugs in new cancer therapies. However, only the structure of the NBD of hHsp70 was solved by X-ray. Truncated structures comprising both the NBD and the SBD were solved for the bacterial E. coli Hsp70 homolog in the closed state (PDB ID: 2KHO) and for the yeast S. cerevisiae Hsp110 homolog in the open state (PDB ID: 3C7N). | + | The Hsp70s assists in the folding of other proteins through cycles of binding and release of unfolded polypeptide chains in the SBD (Figure 1). The cycle is governed by the nucleotide-binding status of the NBD: in the ATP-bound Hsp70, the SBD is opened with fast binding and release of the protein substrate and the SBD and the NBD are docked (Figure 1), whereas in the ADP-bound and nucleotide-free states (APO), the SBD is assumed to be closed with low binding and release rate of the protein substrate, with the SBD and the NBD undocked (Figure 1). The transition between the ATP (open conformation) and the ADP states of Hsp70 (closed conformation) is triggered by the ATP binding to the NBD, which induces a conformational change of the interdomain linker, and the opening of the SBD through an allosteric mechanism which is not fully elucidated. The ATP hydrolysis restores the closed conformation of the SBD. Rebinding of ATP to the nucleotide-free Hsp70 restarts the cycle of the chaperone. In vivo, the ATP hydrolysis and nucleotide exchange rates are increased by co-chaperones. Because of their critical roles in many cellular processes and based on evidence that their mechanisms involve cycles of conformational changes, there has been a strong interest in elucidating the structures of human Hsp70 in its two main conformations, i.e. ATP and ADP-bound. Structures of human Hsp70 are of first interest for the design of drugs in new cancer therapies. However, only the structure of the NBD of hHsp70 was solved by X-ray. Truncated structures comprising both the NBD and the SBD were solved for the bacterial E. coli Hsp70 homolog in the closed state (PDB ID: 2KHO) and for the yeast S. cerevisiae Hsp110 homolog in the open state (PDB ID: 3C7N). |
+ | |||
4. Conformational heterogeneity observed in MD simulations | 4. Conformational heterogeneity observed in MD simulations | ||
Prompted by the absence of detailed atomic experimental structures, we carried out the task of generating computer models of the human Hsp70 in its open and closed states by homology modeling and by molecular dynamics (MD) simulations on a unprecedented micro-second timescale, using the templates PDB ID: 3C7N and PDB ID: 2KHO, respectively. The sequence of human inducible Hsp70 (UniProt ID: P08107) was chosen for modeling purposes because it has been reported as a new target for cancer therapies. | Prompted by the absence of detailed atomic experimental structures, we carried out the task of generating computer models of the human Hsp70 in its open and closed states by homology modeling and by molecular dynamics (MD) simulations on a unprecedented micro-second timescale, using the templates PDB ID: 3C7N and PDB ID: 2KHO, respectively. The sequence of human inducible Hsp70 (UniProt ID: P08107) was chosen for modeling purposes because it has been reported as a new target for cancer therapies. |
Revision as of 09:28, 3 October 2012
|
- ↑ REF
This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.